NDC product
Quit Smoking Symptom Relief
NDC 0220-9318 · Boiron
Key facts
| Product NDC | 0220-9318 |
|---|---|
| Proprietary name | Quit Smoking Symptom Relief |
| Nonproprietary name | LOBELIA INFLATA WHOLE, STRYCHNOS NUX-VOMICA SEED |
| Substances | LOBELIA INFLATA, STRYCHNOS NUX-VOMICA SEED |
| Dosage form | PELLET |
| Route | ORAL |
| Labeler | Boiron |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS] and 1 more |
| Marketing start | Jul 5, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: